WHO Launched Digital Version Of Essential Medicines List 28/02/2020 Editorial team The World Health Organization launched the first-ever digital version of its latest Model list of Essential Medicines (EML) on Thursday. The move is the latest step in WHO’s effort to explore technology in a new focus on digital health. “For more than 40 years, the list has become a reliable and credible source of the most […] Continue reading -> Former Director Of Italian Medicines Agency Recognized For Drug Transparency Work 26/02/2020 Editorial team Former general director of the Italian Medicines Agency (AIFA) Luca Li Bassi was awarded the 2019 “International Transparency in Medicines Policies Awards” by the French civil society watchdog group l’Observatoire Médicaments Transparences (the Observatory for Transparency in Medicines), for his efforts in negotiating a milestone World Health Assembly resolution in May 2019 supporting more public […] Continue reading -> New Coronavirus Has A Name – COVID-19; But As WHO Convenes Global Research Forum Many Other Unknowns Remain 11/02/2020 Elaine Ruth Fletcher The novel coronavirus has been officially named by the World Health Organization as COVID-19, in the first day of a global consultation with about 400 researchers and public health experts charged with designing a coherent way forward to confront the expanding epidemic. However, as the case count rose by Tuesday afternoon to 42,747 people with […] Continue reading -> Over 30 Antiviral Drugs Being Tested Against Novel Coronavirus – As WHO Convenes Global Innovation Forum 10/02/2020 Elaine Ruth Fletcher “We all have a vested interest to stop this epidemic,” says Thomas Cueni, Director General of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA). As WHO on Tuesday convenes a Global Research & Innovation Forum to rapidly ramp up R&D, Cueni spoke with Health Policy Watch about what he describes as “the extraordinary willingness […] Continue reading -> In Effort To Develop Coronavirus Vaccine, Outbreak Expert Sees ‘Hardest Problem’ Of His Career 10/02/2020 STAT News - by Helen Branswell [STAT News] As China struggles to contain an epidemic caused by a new coronavirus, science is racing to develop vaccines to blunt the outbreak’s impact. Central to the effort is CEPI — the Oslo, Norway-based Coalition for Epidemic Preparedness Innovations — a global partnership created to spearhead development of vaccines in just this type of […] Continue reading -> R&D Funding For Leading Infectious Diseases Reaches Record High; But Investments Plateau For Neglected Tropical Diseases 30/01/2020 Grace Ren and Elaine Ruth Fletcher Funding to develop new drugs for some of the world’s leading infectious disease killers, such as HIV/AIDS, TB and malaria, reached a record high of US $4 billion in 2018, with private sector investment driving much of the increase, according to the 2019 G-FINDER Report, which tracks such investments globally. However, investments in neglected tropical […] Continue reading -> Low Antibiotic Prices Dampen Industry Investment In Vital New Tools To Combat Superbugs – Says AMR Industry Alliance 16/01/2020 Elaine Ruth Fletcher The low worldwide prices for antibiotics, combined with the need to carefully ration sale of any powerful new drugs that come to market to preserve their efficacy, continue to dampen industry investment in desperately-needed treatments for new drug-resistant superbugs, according to a sweeping new report by the AMR Industry Alliance, released today. While civil society […] Continue reading -> Transparency & Collaboration Key To Defining A “Fair” Price For Essential Medicines 14/01/2020 Grace Ren More public disclosure and information-sharing about drug prices and their R&D costs, is key to determining a fair price for essential medicines, concludes a series of five articles on fair pricing published Monday in the BMJ. The series, supported in part by the World Health Organization, highlights the increased priority drug price transparency is receiving […] Continue reading -> Immunization And Surveillance Help Stop Polio Outbreaks In 3 African Countries, Says WHO 23/12/2019 Editorial team [UN News] Kenya, Mozambique and Niger curbed different outbreaks of vaccine-derived poliovirus over the past 24 months which affected 14 children, said a senior WHO official on Monday. Although wild poliovirus virus has not been detected in Africa since 2016, roughly 12 countries are currently facing outbreaks of vaccine-derived poliovirus. “Ending outbreaks in the three […] Continue reading -> Novartis Relinquishes European Patent For Kymriah Cancer Cell Therapy 17/12/2019 Editorial team Novartis has relinquished a patent granted by the European Patent Office for Kymriah, a promising new gene therapy for certain forms of leukemia, claiming the patent was no longer essential to the development and marketing of the treatment. The decision followed the moves by the Swiss-based NGO, Public Eye and the French-based Doctors of the […] Continue reading -> Posts navigation Older postsNewer posts
Former Director Of Italian Medicines Agency Recognized For Drug Transparency Work 26/02/2020 Editorial team Former general director of the Italian Medicines Agency (AIFA) Luca Li Bassi was awarded the 2019 “International Transparency in Medicines Policies Awards” by the French civil society watchdog group l’Observatoire Médicaments Transparences (the Observatory for Transparency in Medicines), for his efforts in negotiating a milestone World Health Assembly resolution in May 2019 supporting more public […] Continue reading -> New Coronavirus Has A Name – COVID-19; But As WHO Convenes Global Research Forum Many Other Unknowns Remain 11/02/2020 Elaine Ruth Fletcher The novel coronavirus has been officially named by the World Health Organization as COVID-19, in the first day of a global consultation with about 400 researchers and public health experts charged with designing a coherent way forward to confront the expanding epidemic. However, as the case count rose by Tuesday afternoon to 42,747 people with […] Continue reading -> Over 30 Antiviral Drugs Being Tested Against Novel Coronavirus – As WHO Convenes Global Innovation Forum 10/02/2020 Elaine Ruth Fletcher “We all have a vested interest to stop this epidemic,” says Thomas Cueni, Director General of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA). As WHO on Tuesday convenes a Global Research & Innovation Forum to rapidly ramp up R&D, Cueni spoke with Health Policy Watch about what he describes as “the extraordinary willingness […] Continue reading -> In Effort To Develop Coronavirus Vaccine, Outbreak Expert Sees ‘Hardest Problem’ Of His Career 10/02/2020 STAT News - by Helen Branswell [STAT News] As China struggles to contain an epidemic caused by a new coronavirus, science is racing to develop vaccines to blunt the outbreak’s impact. Central to the effort is CEPI — the Oslo, Norway-based Coalition for Epidemic Preparedness Innovations — a global partnership created to spearhead development of vaccines in just this type of […] Continue reading -> R&D Funding For Leading Infectious Diseases Reaches Record High; But Investments Plateau For Neglected Tropical Diseases 30/01/2020 Grace Ren and Elaine Ruth Fletcher Funding to develop new drugs for some of the world’s leading infectious disease killers, such as HIV/AIDS, TB and malaria, reached a record high of US $4 billion in 2018, with private sector investment driving much of the increase, according to the 2019 G-FINDER Report, which tracks such investments globally. However, investments in neglected tropical […] Continue reading -> Low Antibiotic Prices Dampen Industry Investment In Vital New Tools To Combat Superbugs – Says AMR Industry Alliance 16/01/2020 Elaine Ruth Fletcher The low worldwide prices for antibiotics, combined with the need to carefully ration sale of any powerful new drugs that come to market to preserve their efficacy, continue to dampen industry investment in desperately-needed treatments for new drug-resistant superbugs, according to a sweeping new report by the AMR Industry Alliance, released today. While civil society […] Continue reading -> Transparency & Collaboration Key To Defining A “Fair” Price For Essential Medicines 14/01/2020 Grace Ren More public disclosure and information-sharing about drug prices and their R&D costs, is key to determining a fair price for essential medicines, concludes a series of five articles on fair pricing published Monday in the BMJ. The series, supported in part by the World Health Organization, highlights the increased priority drug price transparency is receiving […] Continue reading -> Immunization And Surveillance Help Stop Polio Outbreaks In 3 African Countries, Says WHO 23/12/2019 Editorial team [UN News] Kenya, Mozambique and Niger curbed different outbreaks of vaccine-derived poliovirus over the past 24 months which affected 14 children, said a senior WHO official on Monday. Although wild poliovirus virus has not been detected in Africa since 2016, roughly 12 countries are currently facing outbreaks of vaccine-derived poliovirus. “Ending outbreaks in the three […] Continue reading -> Novartis Relinquishes European Patent For Kymriah Cancer Cell Therapy 17/12/2019 Editorial team Novartis has relinquished a patent granted by the European Patent Office for Kymriah, a promising new gene therapy for certain forms of leukemia, claiming the patent was no longer essential to the development and marketing of the treatment. The decision followed the moves by the Swiss-based NGO, Public Eye and the French-based Doctors of the […] Continue reading -> Posts navigation Older postsNewer posts
New Coronavirus Has A Name – COVID-19; But As WHO Convenes Global Research Forum Many Other Unknowns Remain 11/02/2020 Elaine Ruth Fletcher The novel coronavirus has been officially named by the World Health Organization as COVID-19, in the first day of a global consultation with about 400 researchers and public health experts charged with designing a coherent way forward to confront the expanding epidemic. However, as the case count rose by Tuesday afternoon to 42,747 people with […] Continue reading -> Over 30 Antiviral Drugs Being Tested Against Novel Coronavirus – As WHO Convenes Global Innovation Forum 10/02/2020 Elaine Ruth Fletcher “We all have a vested interest to stop this epidemic,” says Thomas Cueni, Director General of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA). As WHO on Tuesday convenes a Global Research & Innovation Forum to rapidly ramp up R&D, Cueni spoke with Health Policy Watch about what he describes as “the extraordinary willingness […] Continue reading -> In Effort To Develop Coronavirus Vaccine, Outbreak Expert Sees ‘Hardest Problem’ Of His Career 10/02/2020 STAT News - by Helen Branswell [STAT News] As China struggles to contain an epidemic caused by a new coronavirus, science is racing to develop vaccines to blunt the outbreak’s impact. Central to the effort is CEPI — the Oslo, Norway-based Coalition for Epidemic Preparedness Innovations — a global partnership created to spearhead development of vaccines in just this type of […] Continue reading -> R&D Funding For Leading Infectious Diseases Reaches Record High; But Investments Plateau For Neglected Tropical Diseases 30/01/2020 Grace Ren and Elaine Ruth Fletcher Funding to develop new drugs for some of the world’s leading infectious disease killers, such as HIV/AIDS, TB and malaria, reached a record high of US $4 billion in 2018, with private sector investment driving much of the increase, according to the 2019 G-FINDER Report, which tracks such investments globally. However, investments in neglected tropical […] Continue reading -> Low Antibiotic Prices Dampen Industry Investment In Vital New Tools To Combat Superbugs – Says AMR Industry Alliance 16/01/2020 Elaine Ruth Fletcher The low worldwide prices for antibiotics, combined with the need to carefully ration sale of any powerful new drugs that come to market to preserve their efficacy, continue to dampen industry investment in desperately-needed treatments for new drug-resistant superbugs, according to a sweeping new report by the AMR Industry Alliance, released today. While civil society […] Continue reading -> Transparency & Collaboration Key To Defining A “Fair” Price For Essential Medicines 14/01/2020 Grace Ren More public disclosure and information-sharing about drug prices and their R&D costs, is key to determining a fair price for essential medicines, concludes a series of five articles on fair pricing published Monday in the BMJ. The series, supported in part by the World Health Organization, highlights the increased priority drug price transparency is receiving […] Continue reading -> Immunization And Surveillance Help Stop Polio Outbreaks In 3 African Countries, Says WHO 23/12/2019 Editorial team [UN News] Kenya, Mozambique and Niger curbed different outbreaks of vaccine-derived poliovirus over the past 24 months which affected 14 children, said a senior WHO official on Monday. Although wild poliovirus virus has not been detected in Africa since 2016, roughly 12 countries are currently facing outbreaks of vaccine-derived poliovirus. “Ending outbreaks in the three […] Continue reading -> Novartis Relinquishes European Patent For Kymriah Cancer Cell Therapy 17/12/2019 Editorial team Novartis has relinquished a patent granted by the European Patent Office for Kymriah, a promising new gene therapy for certain forms of leukemia, claiming the patent was no longer essential to the development and marketing of the treatment. The decision followed the moves by the Swiss-based NGO, Public Eye and the French-based Doctors of the […] Continue reading -> Posts navigation Older postsNewer posts
Over 30 Antiviral Drugs Being Tested Against Novel Coronavirus – As WHO Convenes Global Innovation Forum 10/02/2020 Elaine Ruth Fletcher “We all have a vested interest to stop this epidemic,” says Thomas Cueni, Director General of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA). As WHO on Tuesday convenes a Global Research & Innovation Forum to rapidly ramp up R&D, Cueni spoke with Health Policy Watch about what he describes as “the extraordinary willingness […] Continue reading -> In Effort To Develop Coronavirus Vaccine, Outbreak Expert Sees ‘Hardest Problem’ Of His Career 10/02/2020 STAT News - by Helen Branswell [STAT News] As China struggles to contain an epidemic caused by a new coronavirus, science is racing to develop vaccines to blunt the outbreak’s impact. Central to the effort is CEPI — the Oslo, Norway-based Coalition for Epidemic Preparedness Innovations — a global partnership created to spearhead development of vaccines in just this type of […] Continue reading -> R&D Funding For Leading Infectious Diseases Reaches Record High; But Investments Plateau For Neglected Tropical Diseases 30/01/2020 Grace Ren and Elaine Ruth Fletcher Funding to develop new drugs for some of the world’s leading infectious disease killers, such as HIV/AIDS, TB and malaria, reached a record high of US $4 billion in 2018, with private sector investment driving much of the increase, according to the 2019 G-FINDER Report, which tracks such investments globally. However, investments in neglected tropical […] Continue reading -> Low Antibiotic Prices Dampen Industry Investment In Vital New Tools To Combat Superbugs – Says AMR Industry Alliance 16/01/2020 Elaine Ruth Fletcher The low worldwide prices for antibiotics, combined with the need to carefully ration sale of any powerful new drugs that come to market to preserve their efficacy, continue to dampen industry investment in desperately-needed treatments for new drug-resistant superbugs, according to a sweeping new report by the AMR Industry Alliance, released today. While civil society […] Continue reading -> Transparency & Collaboration Key To Defining A “Fair” Price For Essential Medicines 14/01/2020 Grace Ren More public disclosure and information-sharing about drug prices and their R&D costs, is key to determining a fair price for essential medicines, concludes a series of five articles on fair pricing published Monday in the BMJ. The series, supported in part by the World Health Organization, highlights the increased priority drug price transparency is receiving […] Continue reading -> Immunization And Surveillance Help Stop Polio Outbreaks In 3 African Countries, Says WHO 23/12/2019 Editorial team [UN News] Kenya, Mozambique and Niger curbed different outbreaks of vaccine-derived poliovirus over the past 24 months which affected 14 children, said a senior WHO official on Monday. Although wild poliovirus virus has not been detected in Africa since 2016, roughly 12 countries are currently facing outbreaks of vaccine-derived poliovirus. “Ending outbreaks in the three […] Continue reading -> Novartis Relinquishes European Patent For Kymriah Cancer Cell Therapy 17/12/2019 Editorial team Novartis has relinquished a patent granted by the European Patent Office for Kymriah, a promising new gene therapy for certain forms of leukemia, claiming the patent was no longer essential to the development and marketing of the treatment. The decision followed the moves by the Swiss-based NGO, Public Eye and the French-based Doctors of the […] Continue reading -> Posts navigation Older postsNewer posts
In Effort To Develop Coronavirus Vaccine, Outbreak Expert Sees ‘Hardest Problem’ Of His Career 10/02/2020 STAT News - by Helen Branswell [STAT News] As China struggles to contain an epidemic caused by a new coronavirus, science is racing to develop vaccines to blunt the outbreak’s impact. Central to the effort is CEPI — the Oslo, Norway-based Coalition for Epidemic Preparedness Innovations — a global partnership created to spearhead development of vaccines in just this type of […] Continue reading -> R&D Funding For Leading Infectious Diseases Reaches Record High; But Investments Plateau For Neglected Tropical Diseases 30/01/2020 Grace Ren and Elaine Ruth Fletcher Funding to develop new drugs for some of the world’s leading infectious disease killers, such as HIV/AIDS, TB and malaria, reached a record high of US $4 billion in 2018, with private sector investment driving much of the increase, according to the 2019 G-FINDER Report, which tracks such investments globally. However, investments in neglected tropical […] Continue reading -> Low Antibiotic Prices Dampen Industry Investment In Vital New Tools To Combat Superbugs – Says AMR Industry Alliance 16/01/2020 Elaine Ruth Fletcher The low worldwide prices for antibiotics, combined with the need to carefully ration sale of any powerful new drugs that come to market to preserve their efficacy, continue to dampen industry investment in desperately-needed treatments for new drug-resistant superbugs, according to a sweeping new report by the AMR Industry Alliance, released today. While civil society […] Continue reading -> Transparency & Collaboration Key To Defining A “Fair” Price For Essential Medicines 14/01/2020 Grace Ren More public disclosure and information-sharing about drug prices and their R&D costs, is key to determining a fair price for essential medicines, concludes a series of five articles on fair pricing published Monday in the BMJ. The series, supported in part by the World Health Organization, highlights the increased priority drug price transparency is receiving […] Continue reading -> Immunization And Surveillance Help Stop Polio Outbreaks In 3 African Countries, Says WHO 23/12/2019 Editorial team [UN News] Kenya, Mozambique and Niger curbed different outbreaks of vaccine-derived poliovirus over the past 24 months which affected 14 children, said a senior WHO official on Monday. Although wild poliovirus virus has not been detected in Africa since 2016, roughly 12 countries are currently facing outbreaks of vaccine-derived poliovirus. “Ending outbreaks in the three […] Continue reading -> Novartis Relinquishes European Patent For Kymriah Cancer Cell Therapy 17/12/2019 Editorial team Novartis has relinquished a patent granted by the European Patent Office for Kymriah, a promising new gene therapy for certain forms of leukemia, claiming the patent was no longer essential to the development and marketing of the treatment. The decision followed the moves by the Swiss-based NGO, Public Eye and the French-based Doctors of the […] Continue reading -> Posts navigation Older postsNewer posts
R&D Funding For Leading Infectious Diseases Reaches Record High; But Investments Plateau For Neglected Tropical Diseases 30/01/2020 Grace Ren and Elaine Ruth Fletcher Funding to develop new drugs for some of the world’s leading infectious disease killers, such as HIV/AIDS, TB and malaria, reached a record high of US $4 billion in 2018, with private sector investment driving much of the increase, according to the 2019 G-FINDER Report, which tracks such investments globally. However, investments in neglected tropical […] Continue reading -> Low Antibiotic Prices Dampen Industry Investment In Vital New Tools To Combat Superbugs – Says AMR Industry Alliance 16/01/2020 Elaine Ruth Fletcher The low worldwide prices for antibiotics, combined with the need to carefully ration sale of any powerful new drugs that come to market to preserve their efficacy, continue to dampen industry investment in desperately-needed treatments for new drug-resistant superbugs, according to a sweeping new report by the AMR Industry Alliance, released today. While civil society […] Continue reading -> Transparency & Collaboration Key To Defining A “Fair” Price For Essential Medicines 14/01/2020 Grace Ren More public disclosure and information-sharing about drug prices and their R&D costs, is key to determining a fair price for essential medicines, concludes a series of five articles on fair pricing published Monday in the BMJ. The series, supported in part by the World Health Organization, highlights the increased priority drug price transparency is receiving […] Continue reading -> Immunization And Surveillance Help Stop Polio Outbreaks In 3 African Countries, Says WHO 23/12/2019 Editorial team [UN News] Kenya, Mozambique and Niger curbed different outbreaks of vaccine-derived poliovirus over the past 24 months which affected 14 children, said a senior WHO official on Monday. Although wild poliovirus virus has not been detected in Africa since 2016, roughly 12 countries are currently facing outbreaks of vaccine-derived poliovirus. “Ending outbreaks in the three […] Continue reading -> Novartis Relinquishes European Patent For Kymriah Cancer Cell Therapy 17/12/2019 Editorial team Novartis has relinquished a patent granted by the European Patent Office for Kymriah, a promising new gene therapy for certain forms of leukemia, claiming the patent was no longer essential to the development and marketing of the treatment. The decision followed the moves by the Swiss-based NGO, Public Eye and the French-based Doctors of the […] Continue reading -> Posts navigation Older postsNewer posts
Low Antibiotic Prices Dampen Industry Investment In Vital New Tools To Combat Superbugs – Says AMR Industry Alliance 16/01/2020 Elaine Ruth Fletcher The low worldwide prices for antibiotics, combined with the need to carefully ration sale of any powerful new drugs that come to market to preserve their efficacy, continue to dampen industry investment in desperately-needed treatments for new drug-resistant superbugs, according to a sweeping new report by the AMR Industry Alliance, released today. While civil society […] Continue reading -> Transparency & Collaboration Key To Defining A “Fair” Price For Essential Medicines 14/01/2020 Grace Ren More public disclosure and information-sharing about drug prices and their R&D costs, is key to determining a fair price for essential medicines, concludes a series of five articles on fair pricing published Monday in the BMJ. The series, supported in part by the World Health Organization, highlights the increased priority drug price transparency is receiving […] Continue reading -> Immunization And Surveillance Help Stop Polio Outbreaks In 3 African Countries, Says WHO 23/12/2019 Editorial team [UN News] Kenya, Mozambique and Niger curbed different outbreaks of vaccine-derived poliovirus over the past 24 months which affected 14 children, said a senior WHO official on Monday. Although wild poliovirus virus has not been detected in Africa since 2016, roughly 12 countries are currently facing outbreaks of vaccine-derived poliovirus. “Ending outbreaks in the three […] Continue reading -> Novartis Relinquishes European Patent For Kymriah Cancer Cell Therapy 17/12/2019 Editorial team Novartis has relinquished a patent granted by the European Patent Office for Kymriah, a promising new gene therapy for certain forms of leukemia, claiming the patent was no longer essential to the development and marketing of the treatment. The decision followed the moves by the Swiss-based NGO, Public Eye and the French-based Doctors of the […] Continue reading -> Posts navigation Older postsNewer posts
Transparency & Collaboration Key To Defining A “Fair” Price For Essential Medicines 14/01/2020 Grace Ren More public disclosure and information-sharing about drug prices and their R&D costs, is key to determining a fair price for essential medicines, concludes a series of five articles on fair pricing published Monday in the BMJ. The series, supported in part by the World Health Organization, highlights the increased priority drug price transparency is receiving […] Continue reading -> Immunization And Surveillance Help Stop Polio Outbreaks In 3 African Countries, Says WHO 23/12/2019 Editorial team [UN News] Kenya, Mozambique and Niger curbed different outbreaks of vaccine-derived poliovirus over the past 24 months which affected 14 children, said a senior WHO official on Monday. Although wild poliovirus virus has not been detected in Africa since 2016, roughly 12 countries are currently facing outbreaks of vaccine-derived poliovirus. “Ending outbreaks in the three […] Continue reading -> Novartis Relinquishes European Patent For Kymriah Cancer Cell Therapy 17/12/2019 Editorial team Novartis has relinquished a patent granted by the European Patent Office for Kymriah, a promising new gene therapy for certain forms of leukemia, claiming the patent was no longer essential to the development and marketing of the treatment. The decision followed the moves by the Swiss-based NGO, Public Eye and the French-based Doctors of the […] Continue reading -> Posts navigation Older postsNewer posts
Immunization And Surveillance Help Stop Polio Outbreaks In 3 African Countries, Says WHO 23/12/2019 Editorial team [UN News] Kenya, Mozambique and Niger curbed different outbreaks of vaccine-derived poliovirus over the past 24 months which affected 14 children, said a senior WHO official on Monday. Although wild poliovirus virus has not been detected in Africa since 2016, roughly 12 countries are currently facing outbreaks of vaccine-derived poliovirus. “Ending outbreaks in the three […] Continue reading -> Novartis Relinquishes European Patent For Kymriah Cancer Cell Therapy 17/12/2019 Editorial team Novartis has relinquished a patent granted by the European Patent Office for Kymriah, a promising new gene therapy for certain forms of leukemia, claiming the patent was no longer essential to the development and marketing of the treatment. The decision followed the moves by the Swiss-based NGO, Public Eye and the French-based Doctors of the […] Continue reading -> Posts navigation Older postsNewer posts
Novartis Relinquishes European Patent For Kymriah Cancer Cell Therapy 17/12/2019 Editorial team Novartis has relinquished a patent granted by the European Patent Office for Kymriah, a promising new gene therapy for certain forms of leukemia, claiming the patent was no longer essential to the development and marketing of the treatment. The decision followed the moves by the Swiss-based NGO, Public Eye and the French-based Doctors of the […] Continue reading -> Posts navigation Older postsNewer posts